Enthusiasm Ebbs for a Diversity Initiative in Venture Capital

[ad_1] Jan. 10, 2024 7:00 am ET|WSJ Pro Efforts to diversify the venture capital industry have been losing steam, strained by a market downturn as well as a broader debate…

Jobs Platform Gigs Is Looking for the Hourly Worker

[ad_1] Dec. 17, 2023 10:00 am ET|WSJ Pro In the U.S. labor market, demand is holding up for food and hospitality personnel, less so for software developers. That has startup…

Biotech Companies Tap Saudi Arabia for Venture Funding

[ad_1] Nov. 10, 2023 6:00 am ET|WSJ Pro Some biotechnology startups are raising capital from Saudi Arabia as U.S. venture funding retreats and Middle East countries seek to boost their…

WSJ News Exclusive | Springcoast Gathers More Than $500 Million So Far for Small Technology Deals

[ad_1] Oct. 18, 2023 2:28 pm ET|WSJ Pro Technology-focused Springcoast Capital Partners has amassed more than $500 million so far for its debut commingled fund and a related investment vehicle,…

FemHealth Ventures Closes $32 Million Fund for Women’s Health Investments

[ad_1] Fundraising came in above the goal but below the $50 million hard cap as the new venture firm faced obstacles raising its first fund. [ad_2] Source link

Paul Hsu of Crypto Venture Firm Decasonic Weighs in on Sector’s Future

[ad_1] It is a rough time to be a crypto investor. Global venture funding for crypto startups fell 83% to $2 billion in the second quarter from its peak in…

More Startups Throw in the Towel, Unable to Raise Money for Their Ideas

[ad_1] Startup shutdowns, fire sales and hard pivots are under way in the face of a downturn in the venture market. [ad_2] Source link

Startups’ Patch Technologies Could Extend Reach of Vaccines

[ad_1] In several countries the effort to eradicate measles runs into the logistical obstacle of insufficient cold storage for vaccines.    Patches from startups including Micron Biomedical and Vaxxas could overcome…

Drug Developer Acelyrin Raises $540 Million in IPO

[ad_1] Drugmaker Acelyrin has raised $540 million through an initial public offering despite a chilly market for biotechnology companies seeking to make their stock-market debuts. Acelyrin, based in the Los…

Startups Face Murky Outlook as Venture-Capital Slump Deepens

[ad_1] A prolonged slump in venture-capital deal making deepened over the first quarter, setting the stage for a tough year ahead for startups, particularly mature private companies seeking exit opportunities…